Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Portlock

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|July 15, 2006
Anti-angiogenesis and diffuse large B-cell lymphoma: a new treatment opportunity?C Portlock
The New England Journal of Medicine|September 14, 1995
Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphomaS D Nimer, A Zelenetz, C Portlock
Current Problems in Cancer|January 1, 1991
Autologous bone marrow transplantationS C Gulati, J Yahalom, C Portlock
Neurology|June 1, 1977
Nonhypoxemic hazards of prolonged myoclonusJ W Langston, D R Ricci, C Portlock
Spine|October 2, 2007
Safety of chiropractic manipulation of the cervical spine: a prospective national surveyHaymo W Thiel, Jennifer E Bolton, Sharon Docherty, et al.
Cancer|October 1, 1991
Stage I and II subdiaphragmatic Hodgkin's diseaseD H Mai, R E Peschel, C Portlock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphomaS Teckie, S Qi, M Chelius, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1992
Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinumL Kostakoglu, S D Yeh, C Portlock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patientsJ Teruya-Feldstein, E Chiao, D A Filippa, et al.
Blood|April 1, 1996
CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's diseaseD A Filippa, M Ladanyi, N Wollner, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|July 15, 2006
Anti-angiogenesis and diffuse large B-cell lymphoma: a new treatment opportunity?C Portlock
The New England Journal of Medicine|September 14, 1995
Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphomaS D Nimer, A Zelenetz, C Portlock
Current Problems in Cancer|January 1, 1991
Autologous bone marrow transplantationS C Gulati, J Yahalom, C Portlock
Neurology|June 1, 1977
Nonhypoxemic hazards of prolonged myoclonusJ W Langston, D R Ricci, C Portlock
Spine|October 2, 2007
Safety of chiropractic manipulation of the cervical spine: a prospective national surveyHaymo W Thiel, Jennifer E Bolton, Sharon Docherty, et al.
Cancer|October 1, 1991
Stage I and II subdiaphragmatic Hodgkin's diseaseD H Mai, R E Peschel, C Portlock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphomaS Teckie, S Qi, M Chelius, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1992
Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinumL Kostakoglu, S D Yeh, C Portlock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patientsJ Teruya-Feldstein, E Chiao, D A Filippa, et al.
Blood|April 1, 1996
CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's diseaseD A Filippa, M Ladanyi, N Wollner, et al.
Pageof 3